United States - English - NLM (National Library of Medicine)

deremetrx llc - sodium ascorbate (unii: s033eh8359) (ascorbic acid - unii:pq6ck8pd0r), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), tocophersolan (unii: o03s90u1f2) (tocophersolan - unii:o03s90u1f2), thiamine mononitrate (unii: 8k0i04919x) (thiamine ion - unii:4abt0j945j), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), folic acid (unii: - sodium ascorbate 120 mg - indications and usage:  pre-tabs dha is indicated to provide vitamin/mineral and omega-3 fatty acid supplementation to women throughout pregnancy, during the postnatal for both lactating and nonlactating mothers. pre-tabs dha is also beneficial in improving the nutritional status of women prior to conception. contraindications: this product is contraindicated in patients with a known hypersensitivity to any of the ingredients .

Philippines - English - FDA (Food And Drug Administration)

metz pharmaceuticals, inc. - ascorbic acid , cholecalciferol , zinc - capsule classification: over-the-counter (otc) - 500 mg (equivalent to 562.43 mg sodium ascorbate) 1,000 iu/10 mg (equivalent to 70 mg zinc gluconate) dosage

Australia - English - Department of Health (Therapeutic Goods Administration)

orthomolecular medisearch laboratories pty ltd trading as biological therapies - sodium ascorbate, quantity: 250 g/l - injection, intravenous infusion - excipient ingredients: water for injections - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code) sodium ascorbate injections are indicated for the treatment of vitamin c deficiency when oral treatment is not feasible

Australia - English - Department of Health (Therapeutic Goods Administration)

disodium edetate; sodium ascorbate -

Australia - English - Department of Health (Therapeutic Goods Administration)

disodium edetate; sodium ascorbate -

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - sodium ascorbate, quantity: 113 mg (equivalent: ascorbic acid, qty 100 mg); folic acid, quantity: 0.4 mg; pyridoxine hydrochloride, quantity: 4.9 mg (equivalent: pyridoxine, qty 4 mg); nicotinamide, quantity: 40 mg; cyanocobalamin, quantity: 5 microgram; thiamine nitrate, quantity: 3.1 mg; biotin, quantity: 60 microgram; sodium pantothenate, quantity: 16.5 mg (equivalent: pantothenic acid, qty 15 mg); riboflavine sodium phosphate, quantity: 4.9 mg (equivalent: riboflavine, qty 3.6 mg) - injection, powder for - excipient ingredients: edetate sodium; methyl hydroxybenzoate; glycine - soluvit n is intended as a supplement in intravenous nutrition in order to meet the daily requirements of the water-soluble vitamins in adults, adolescents, children and infants. fat-soluble vitamins should also be administered to patients receiving prolonged parenteral nutrition.

Australia - English - Department of Health (Therapeutic Goods Administration)

norgine pty ltd - sodium sulfate, quantity: 7.5 g; macrogol 3350, quantity: 100 g; potassium chloride, quantity: 1.015 g; ascorbic acid, quantity: 4.7 g; sodium ascorbate, quantity: 5.9 g; sodium chloride, quantity: 2.691 g - powder - excipient ingredients: acesulfame potassium; aspartame; flavour - for bowel cleansing prior to any clinical procedure requiring a clean bowel e.g. bowel endoscopy, lower gastrointestinal tract radiology or digestive tract surgery.

Australia - English - Department of Health (Therapeutic Goods Administration)

orthomolecular medisearch laboratories pty ltd trading as biological therapies - sodium ascorbate, quantity: 112.49 mg/ml (equivalent: ascorbic acid, qty 100 mg/ml) - injection - excipient ingredients: water for injections - for the treatment of vitamin c deficiency when oral administration is not feasible.

Australia - English - Department of Health (Therapeutic Goods Administration)

orthomolecular medisearch laboratories pty ltd trading as biological therapies - sodium ascorbate, quantity: 300 mg/ml - injection, solution - excipient ingredients: water for injections - for the treatment of vitamin c deficiency when oral treatment is not feasible.

Israel - English - Ministry of Health

teva medical marketing ltd. - sodium chloride - solution for infusion - sodium chloride 0.9 %w/v - sodium chloride - sodium chloride - treatment of isotonic extracellular dehydration. treatment of sodium depletion. vehicle or diluent of compatible drugs for parenteral administration.